Egetis Therapeutics AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	142.5	215.8	351	303.3	127.7	144
Cash & Short-Term Investments	142.5	215.8	351	303.3	127.7	144
Cash Growth	-47.76%	-38.52%	15.73%	137.51%	-11.32%	-49.97%
Accounts Receivable	5.2	19.2	15.5	28.2	3.8	3.5
Other Receivables	7.1	8.7	8.1	8.4	6.7	3.3
Receivables	12.3	27.9	23.6	36.6	10.5	6.8
Inventory	1.8	2.3	1	0.7	0.6	0.7
Prepaid Expenses	6.6	4.3	4.1	4.4	8.2	1.3
Other Current Assets	-	3.3	0.4	0.9	0.4	0.1
Total Current Assets	163.2	253.6	380.1	345.9	147.4	152.9
Property, Plant & Equipment	9	9.7	2.6	4.4	2.7	4.3
Long-Term Investments	-	0.8	0.8	0.8	0.8	0.8
Other Intangible Assets	1.9	2.2	3.2	4.3	5.4	6.5
Long-Term Deferred Tax Assets	1.6	1.7	0.6	-	-	-
Long-Term Deferred Charges	361	371.1	404.8	404.8	404.8	404.8
Other Long-Term Assets	0.7	-	0.2	-	-	-
Total Assets	537.4	639.1	792.3	760.2	561.1	569.3
Accounts Payable	23.1	21.8	25.7	28.7	20	4.6
Accrued Expenses	170.3	170.7	131	47.2	12.7	5.3
Current Portion of Long-Term Debt	32.4	31.5	30.1	5.2	-	-
Current Portion of Leases	-	2.9	2.5	2.2	1.6	1.5
Current Income Taxes Payable	-	0.1	0.2	0.1	-	-
Other Current Liabilities	11	13.9	14.7	20.5	15.1	27.8
Total Current Liabilities	236.8	240.9	204.2	103.9	49.4	39.2
Long-Term Debt	37.9	45	84.1	103.4	-	-
Long-Term Leases	-	5.6	0.4	2.2	1.1	2.7
Long-Term Deferred Tax Liabilities	1.6	1.7	0.5	-	-	-
Other Long-Term Liabilities	12.5	7.2	10.2	5.1	4.4	0.4
Total Liabilities	288.8	300.4	299.4	214.6	54.9	42.3
Common Stock	22.3	22.3	20.4	15.4	11.3	8.7
Additional Paid-In Capital	2,228	2,228	2,058	1,780	1,428	1,263
Retained Earnings	-2,043	-1,948	-1,610	-1,267	-939.6	-745.8
Comprehensive Income & Other	41.6	36.9	24.9	16.7	6.1	1.3
Shareholders' Equity	248.6	338.7	492.9	545.6	506.2	527
Total Liabilities & Equity	537.4	639.1	792.3	760.2	561.1	569.3
Total Debt	70.3	85	117.1	113	2.7	4.2
Net Cash (Debt)	72.2	130.8	233.9	190.3	125	139.8
Net Cash Growth	-56.58%	-44.08%	22.91%	52.24%	-10.59%	-50.63%
Net Cash Per Share	0.19	0.35	0.75	0.73	0.64	0.78
Filing Date Shares Outstanding	395.16	395.16	359.24	292.57	214.59	165.07
Total Common Shares Outstanding	395.16	395.16	359.24	292.57	214.59	165.07
Working Capital	-73.6	12.7	175.9	242	98	113.7
Book Value Per Share	0.63	0.86	1.37	1.86	2.36	3.19
Tangible Book Value	246.7	336.5	489.7	541.3	500.8	520.5
Tangible Book Value Per Share	0.62	0.85	1.36	1.85	2.33	3.15
Machinery	-	1.6	0.1	0.3	0.2	0.3

Source: S&P Global Market Intelligence. Standard template. Financial Sources.